ImmunoScape vs Janux Therapeutics
ImmunoScape vs Janux Therapeutics, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and Janux Therapeutics on 57/100.
Where each one leads
ImmunoScape
Leads on none of the measures we hold for both companies.
Janux Therapeutics
- domain rating: 39/100 against 28/100
- funding raised: $181M against $49.7M
- LinkedIn following: 12,449 against 4,364
At a glance
| Measure | ImmunoScape | Janux Therapeutics |
|---|---|---|
| What it is | Developing novel immunotherapies and diagnostics for cancer. | A clinical-stage biopharmaceutical company developing novel immunotherapies. |
| Category | Biotechnology, Cancer, Immunotherapy, Diagnostics | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2017 |
| Headquarters | Singapore, Singapore | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunoScape | Janux Therapeutics |
|---|---|---|
| Employees | Not published | 110 |
| Total funding | $49.7M | $181M |
| Latest round | Series B2 | Series B |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 4,364 | 12,449 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunoScape | Janux Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 57/100 |
| Traction | 38/100 | 60/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 23/100 | 35/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunoScape | Janux Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
What users say
| Measure | ImmunoScape | Janux Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.”r/Quantisnow
ImmunoScape vs Janux Therapeutics: common questions
Which is better, ImmunoScape or Janux Therapeutics?
On our 0-100 score ImmunoScape rates higher (58/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do ImmunoScape and Janux Therapeutics compare on the numbers?
Janux Therapeutics leads on domain rating (39/100 against 28/100), funding raised ($181M against $49.7M), LinkedIn following (12,449 against 4,364).
What do real users say about ImmunoScape and Janux Therapeutics?
ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.
Read the full ImmunoScape review and pricing or the Janux Therapeutics review and pricing. You can also browse other ImmunoScape alternatives we track.